Moreover, P21 serves as a transcriptional target of the p53 tumor suppressor, and USP39 is able to regulate the stability of P21 by modulating the half-life and promoter activity of P21 in the p53/p21/CDC2/cyclin B1 axis, which in turn regulates colorectal cancer development (26). This evidence concerns the gene TP53 and colorectal cancer.